Comparison of patient-reported outcomes (PROs) during acute exacerbation of chronic obstructive pulmonary disease

Saya Nakamura (Toyokawa-shi, Japan), Saya Nakamura, Masaaki Kusunose, Kazuyoshi Senda, Koichi Nishimura

Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Session: Monitoring airway diseases with clinical tools
Session type: Thematic Poster
Number: 1043
Disease area: Airway diseases

Congress or journal article abstractE-poster

Abstract

BACKGROUND: Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is defined by change of the symptoms. The establishment of a standardized method to quantify and evaluate the symptoms is expected. STUDY OBJECTIVE: We investigated and compared the responsiveness of the Exacerbations of Chronic Pulmonary Disease Tool (EXACT), the COPD Assessment Test (CAT), the St. George's Respiratory Questionnaire (SGRQ), Dyspnea-12 and Hyland Scale (global scale) during the recovery phase from AECOPD. METHOD: We followed 28 patients who had been hospitalized because of AECOPD, and compared the scores of each PROs at the baseline with the scores obtained 14, 28, 56 and 84 days later. RESULTS: The EXACT total score (possible range; 0-100) improved from 50±12 to 32±14, CAT score (possible range; 0-40) from 24±9 to 13±8, the SGRQ score from 55±21 to 41±24, Dyspnea-12 score (possible range; 0-36) from 10±10 to 5±6, and Hyland Scale (possible range; 0-100) from 45±19 to 62±21 during the first 28 days. The effective size of the EXACT total and CAT score was -1.36 and -1.30 respectively, although the SGRQ, Dyspnea-12, and Hyland Scale were less responsive with the effect size of -0.52, -0.64, and 0.82. Therefore, the EXACT total score and CAT score showed best responsiveness. From the perspective of score distribution, only the EXACT total score showed normal distribution. CONCLUSION: The EXACT total score may be the ideal measure during the recovery phase from AECOPD.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Saya Nakamura (Toyokawa-shi, Japan), Saya Nakamura, Masaaki Kusunose, Kazuyoshi Senda, Koichi Nishimura. Comparison of patient-reported outcomes (PROs) during acute exacerbation of chronic obstructive pulmonary disease. Eur Respir J 2016; 48: Suppl. 60, 1043

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Seasonal variation of exacerbation and patient-reported outcomes (PROs) in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2018 – Occupational and environmental lung diseases: inhaled air quality and health effects
Year: 2018


Proactive integrated care improves quality of life in patients with COPD
Source: Eur Respir J 2009; 33: 1031-1038
Year: 2009



The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013


Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)?
Source: Eur Respir J 2001; 18: Suppl. 33, 241s
Year: 2001

The role of inflammatory biomarkers and health related quality of life questionnaires in distinction of exacerbation and stable chronic obstructive pulmonary diseases
Source: International Congress 2014 – Markers
Year: 2014


Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016

A pilot study to assess the efficacy of breathlessness plans for patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016

Comparisons among various QOL assessments and clinical outcomes for one year in elderly patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 66s
Year: 2004

Outcome of pulmonary rehabilitation in patients after acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2)
Year: 2013

Factors associated with exacerbation in a general practitioners’-based Swiss chronic obstructive pulmonary disease (COPD) cohort
Source: Annual Congress 2013 –The best posters in chronic care
Year: 2013


Are re-admissions with acute exacerbation of chronic obstructive pulmonary disease coded correctly?
Source: International Congress 2014 – COPD exacerbations
Year: 2014


An evaluation of the validity of two measurements of dyspnoea as outcomes of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 182s
Year: 2002

Evaluation of adequacy of pharmacological treatment in relation to severity in patients with chronic obstructive pulmonary disease (COPD) and their clinical correlations.
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018

Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort
Source: International Congress 2014 – Clinical presentations
Year: 2014


Acute exacerbations of chronic obstructive pulmonary disease: Is it acute exacerbations of chronic cardiopulmonary disease?
Source: International Congress 2014 – Comorbidities
Year: 2014

Predictors of readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013


Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016


Characteristics and outcomes of hospitalizations for acute exacerbation of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease
Year: 2012


The respiratory microbiome in chronic obstructive pulmonary disease (COPD) exacerbations: Relationships with clinical characteristics
Source: Annual Congress 2012 - Hot topics in respiratory infections
Year: 2012

Bronchiectasis impact outcomes in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008